Can MDMA help psychiatric disorders? Sam Altman and founders of Coinbase and Figma are betting on it
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Arcadia Medicine's presumably ...
Tools for Humanity is broadening its World platform beyond digital identity and crypto payments, adding encrypted messaging and financial services to its app as part of a push toward a super-app model ...
A tech bro coalition is exploring ways to genetically engineer embryos to stave off hereditary diseases, despite the practice being banned in the U.S. Silicon Valley heavyweights Sam Altman of OpenAI ...
Open AI co-founder and CEO Sam Altman launched a project last year called Worldcoin, which uses iris-scanning technology and pays users in cryptocurrency. But governments around the globe are raising ...
CoinDesk's Most Influential 2023 recognizes the people, who, for better or worse, defined the year in digital assets and Web3. There are 10 top honorees who made an outsized impact, and 40 more people ...
A San Francisco-based biotech company, backed by OpenAI’s Sam Altman, has won government approval to begin clinical trials of a new “safer MDMA”. The company, Arcadia Medicine, which is developing ...
Former Chancellor George Osborne is joining OpenAI to assist in the bot developer’s relationships with governments around the ...
They want to escape from regulation and ‘failing’ democracy — but are they more opportunistic than libertarian?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results